| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |